TABLES AND FIGURES 
VII 
DOCUMENT NAME 
DATE 
DESCRIPTION 
DISTRIBUTION 
CONCLUSIONS 
Chancroid 
Undated, but 
Describes the 
Sent to the Director of 
Orvus-mapharsen 
Experiment 
Dr. Cutler 
effectiveness of the 
the VDRL at Chamblee, 
prophylaxis was not 
sent the 
orvus-mapharsen 
Georgia, but with 
effective 
document 
prophylaxis 
some information 
to the 
from an original 
Director of 
draft censored; the 
the Venereal 
Director was asked 
Disease 
to “handle and 
Research 
treat this document 
Laboratory 
as confidential” 
at Chamblee, 
Georgia, in 
Sept. 1952 
(emphasis in original) 
Experimental Studies 
Oct. 29, 
Describes the 
Marked as “SECRET- 
All tested prophylactic 
in Gonorrhea 
1952 
effectiveness, 
CONFIDENTIAL” with 
methods were 
side effects, and 
some identifying 
effective, but the 
drawbacks of 
details masked (e.g., 
orvus-mapharsen 
prophylactic methods 
identities of physicians 
solution was found to 
(10% argyrol solution, 
involved) 
be the best option 
the U.S. Army pro kit, 
No evidence that Dr. 
penicillin, and orvus- 
mapharsen) 
Cutler shared this 
report with anyone 
Final Syphilis Report 
Feb. 24, 
Describes different 
Not marked 
The highest degree 
1955 
methods of 
“confidential,” and no 
of prophylactic 
prophylaxis against 
indication from the 
effectiveness was 
syphilis 
documents that Dr. 
obtained with either 
Describes effects of 
penicillin in treatment 
of syphilis 
Cutler did not intend 
it to circulate, but 
also no record that Dr. 
orvus-mapharsen, 
calomel ointment, 
oral penicillin, 
Cutler ever provided 
or intravenous 
Describes use of 
this report to any 
mapharsen 
serology testing 
outside party 
Penicillin almost 
Describes 
invariably cured 
understanding of 
primary and 
syphilis in man 
secondary syphilis 
No specific serology 
conclusions 
were made 
Various observations 
of syphilis in man were 
recorded 
111 
